WO1999007427A1 - Method and device for administering a quantity of fluid to the nose - Google Patents

Method and device for administering a quantity of fluid to the nose Download PDF

Info

Publication number
WO1999007427A1
WO1999007427A1 PCT/SE1998/001337 SE9801337W WO9907427A1 WO 1999007427 A1 WO1999007427 A1 WO 1999007427A1 SE 9801337 W SE9801337 W SE 9801337W WO 9907427 A1 WO9907427 A1 WO 9907427A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
tube
nostril
nose
shaped
Prior art date
Application number
PCT/SE1998/001337
Other languages
French (fr)
Swedish (sv)
Inventor
Bo Nordebo
Original Assignee
Bo Nordebo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bo Nordebo filed Critical Bo Nordebo
Priority to AU83655/98A priority Critical patent/AU8365598A/en
Publication of WO1999007427A1 publication Critical patent/WO1999007427A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up

Definitions

  • the present invention concerns a method and device for administering a quantity of fluid to the nose.
  • the device utilised according to the invention comprises an inhaler with which a specific quantity of saline solution or other fluid suitable for the purpose can be introduced and thereafter inhaled in the nose.
  • the inhaler consists of a tube, preferably of plastic material, whose one end is arranged as a holder that acts as a measure and that is preferably defined by the said tube being bent at one end to form a curve or water trap.
  • the other end of the said tube is arranged as a nozzle that is shaped as a nostril so that it can be pressed against the said nostril and form an air-tight seal.
  • the said holder is immersed in the said fluid, after which the nozzle is pressed against one nostril and the fluid is inhaled into the nose while the other nostril is sealed-off .
  • a device for a similar purpose as that of the present invention is previously known from US 1 544 164.
  • this known device is neither shaped like the present inhaler nor intended to be used in the way that the present invention states.
  • Decongestant (astringent) medicines are used extensively when treating the symptoms of colds and inflammation of the ear or the sinuses. A number of patients with chronic congestion use such means practically continuously. A number of the most frequently used medicines, such as nose drops that are sold without prescription, are based on oxymetasoline hydrochloride or xylometasoline hydrochloride as active ingredients. It has been known for some time that a considerable overuse of astringent medicines exists. The overuse of the said medicines has been shown to lead to chronic nasal catarrh with symptoms such as a blocked nose and irritated nose in a number of people, symptoms that are clearly the opposite of what is intended.
  • Physiological saline solution has been demonstrated to have a good decongestant effect and is totally free from side effects. So far, it has not been demonstrated that saline gives rise to any side effects such as chronic nasal catarrh in the same way that astringent nasal drops do.
  • the saline should have a concentration of 9 mg/ml sodium chloride and is therefore designated physiological saline solution.
  • the preparation of the saline solution can easily be done by the patients themselves.
  • the means of applying the saline solution to the nose has for a long time been the greatest hinder to its increased use.
  • a self-prepared saline solution with a suitable applicator even has a role in occupational medicine.
  • Certain occupational groups such as welders, sawmill or timber yard workers and those working with insulation, for example, all have an increased need to clear the nasal air passages as their work is carried out in particularly dusty or badly polluted environments.
  • the simple nose inhaler according to the invention is a useful aid when administering physiological saline solution for colds, inflamed sinuses, chronic nasal catarrh and within occupational medicine. It solves in a simple way the problem of obtaining a suitable dose of the solution and of inhaling this. This and other problems are solved according to the invention by it having the distinguishing characteristics that are given in the following claims.
  • Fig. 1 shows a perspective view of a first embodiment of a device according to the invention
  • Fig. 2 shows an enlarged longitudinal cross-section through a part of a lower section of the invention according to fig. 1, and
  • Fig. 3 shows a perspective view of a second embodiment of the invention.
  • a first embodiment of the invention is comprised of an elongated tube 1 open at both ends. At one end, the tube 1 is formed as an essentially U- shaped section 2 that is thus adjacent to a long shank 4 and a short shank 3.
  • the U-shaped section is formed as an essentially U- shaped section 2 that is thus adjacent to a long shank 4 and a short shank 3.
  • the long shank 4 of the tube is provided with a nozzle in the form of a widened section 7 around the opening of the tube 8 where the widened section is intended to form a tight connection between the tube and the nostril when it is pressed against this.
  • the widened section 7 has an essentially cone-shaped surface 9, at least on the side that is pointed towards the nostril of a patient 10 during use.
  • the quantity of fluid that then remains in the tube is adapted to that which normally needs to be administered to the nostril. If a smaller quantity of fluid is considered desirable, a part of it can be poured back into the holder by tilting the tube.
  • the fluid is inhaled into each nostril by the widened section 7 of tube 1 being pressed against the nostril while the opposite nostril is sealed-off with, for example, a finger, and the quantity of fluid is inhaled.
  • the fluid is located in the tube's U-shaped section prior to inhalation and as this acts as a water trap, the whole of the quantity of fluid can easily be inhaled.
  • FIG. 3 shows a second embodiment of the invention in which, as in the previously described embodiment, the invention includes a tube-shaped element 4' that at one end is provided with a widened section intended to be pressed tightly to seal against a nostril for the inhalation of a suitable astringent fluid.
  • the holder 5 ' that is arranged at the other end of the tube-shaped element 4 ' and that is intended to be filled with a pre-determined quantity of fluid is defined by a preferably cylindrical circular cup-shaped body 11 to which this end of the said tube-shaped element is arranged in such a way that the open end is situated at the bottom of the cup-shaped body so that the fluid present in the cup can be inhaled through the tube-shaped element 4 ' .

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The invention concerns a method and device for administering a quantity of fluid to the nose. The device utilised comprises an inhaler with which a specific quantity of saline solution or other fluid can be introduced and thereafter inhaled in the nose. The inhaler consists of a tube-shaped element whose one end is arranged as a holder for containing a specific quantity fluid by being immersed in a fluid, whereby the said holder is preferably developed from the said tube-shaped element being bent at one end to form a curve or a water trap, and whose other end is arranged as a nostril-shaped nozzle to press against the said nostril and form an air-tight seal. During a cold or when there is another reason to inhale saline solution into the nose, the tube's curved end is immersed in the said saline solution so that the curve fills with fluid, after which the nozzle is pressed against one nostril and the fluid is inhaled into the nose while the other nostril is sealed-off.

Description

Method and device for administering a quantity of fluid to the nose
The present invention concerns a method and device for administering a quantity of fluid to the nose.
The device utilised according to the invention comprises an inhaler with which a specific quantity of saline solution or other fluid suitable for the purpose can be introduced and thereafter inhaled in the nose. The inhaler consists of a tube, preferably of plastic material, whose one end is arranged as a holder that acts as a measure and that is preferably defined by the said tube being bent at one end to form a curve or water trap. The other end of the said tube is arranged as a nozzle that is shaped as a nostril so that it can be pressed against the said nostril and form an air-tight seal. During a cold or when there is another reason to inhale saline solution into the nose, the said holder is immersed in the said fluid, after which the nozzle is pressed against one nostril and the fluid is inhaled into the nose while the other nostril is sealed-off .
A device for a similar purpose as that of the present invention is previously known from US 1 544 164. However, this known device is neither shaped like the present inhaler nor intended to be used in the way that the present invention states.
Decongestant (astringent) medicines are used extensively when treating the symptoms of colds and inflammation of the ear or the sinuses. A number of patients with chronic congestion use such means practically continuously. A number of the most frequently used medicines, such as nose drops that are sold without prescription, are based on oxymetasoline hydrochloride or xylometasoline hydrochloride as active ingredients. It has been known for some time that a considerable overuse of astringent medicines exists. The overuse of the said medicines has been shown to lead to chronic nasal catarrh with symptoms such as a blocked nose and irritated nose in a number of people, symptoms that are clearly the opposite of what is intended.
Physicians and specialists have long advocated for a transition to milder decongestant medicines when blocked noses or colds become problematic. Physiological saline solution has been demonstrated to have a good decongestant effect and is totally free from side effects. So far, it has not been demonstrated that saline gives rise to any side effects such as chronic nasal catarrh in the same way that astringent nasal drops do. For this application, the saline should have a concentration of 9 mg/ml sodium chloride and is therefore designated physiological saline solution. The preparation of the saline solution can easily be done by the patients themselves. However, the means of applying the saline solution to the nose has for a long time been the greatest hinder to its increased use. A self-prepared saline solution with a suitable applicator even has a role in occupational medicine. Certain occupational groups such as welders, sawmill or timber yard workers and those working with insulation, for example, all have an increased need to clear the nasal air passages as their work is carried out in particularly dusty or badly polluted environments.
The simple nose inhaler according to the invention is a useful aid when administering physiological saline solution for colds, inflamed sinuses, chronic nasal catarrh and within occupational medicine. It solves in a simple way the problem of obtaining a suitable dose of the solution and of inhaling this. This and other problems are solved according to the invention by it having the distinguishing characteristics that are given in the following claims.
The invention is described in more detail below with reference to the enclosed drawings, where:
Fig. 1 shows a perspective view of a first embodiment of a device according to the invention,
Fig. 2 shows an enlarged longitudinal cross-section through a part of a lower section of the invention according to fig. 1, and
Fig. 3 shows a perspective view of a second embodiment of the invention.
With reference to fig. 1 and 2, a first embodiment of the invention is comprised of an elongated tube 1 open at both ends. At one end, the tube 1 is formed as an essentially U- shaped section 2 that is thus adjacent to a long shank 4 and a short shank 3. The U-shaped section
2 defines a holder, generally designated 5, whereby the said U-shaped section, together with the length of the short shank 3 and the device's remaining dimensions, determine the amount of fluid
6 that remains in the curved end of the tube after this has been immersed in a holder containing fluid. At its end, the long shank 4 of the tube is provided with a nozzle in the form of a widened section 7 around the opening of the tube 8 where the widened section is intended to form a tight connection between the tube and the nostril when it is pressed against this. The widened section 7 has an essentially cone-shaped surface 9, at least on the side that is pointed towards the nostril of a patient 10 during use. When the device according to the invention is used, its curved end is first immersed in a holder containing, for example, saline solution, so that the U-shaped section and the shanks are filled up to the length of the short shank 3. The quantity of fluid that then remains in the tube is adapted to that which normally needs to be administered to the nostril. If a smaller quantity of fluid is considered desirable, a part of it can be poured back into the holder by tilting the tube. The fluid is inhaled into each nostril by the widened section 7 of tube 1 being pressed against the nostril while the opposite nostril is sealed-off with, for example, a finger, and the quantity of fluid is inhaled. As the fluid is located in the tube's U-shaped section prior to inhalation and as this acts as a water trap, the whole of the quantity of fluid can easily be inhaled. If the respiratory pathways through the nose are so blocked that it is not possible to inhale, the head can be tilted backwards with the inhaler pressed against one nostril so that the fluid in the inhaler can run down into the nostril. Fig. 3 shows a second embodiment of the invention in which, as in the previously described embodiment, the invention includes a tube-shaped element 4' that at one end is provided with a widened section intended to be pressed tightly to seal against a nostril for the inhalation of a suitable astringent fluid. However, with this embodiment, the holder 5 ' that is arranged at the other end of the tube-shaped element 4 ' and that is intended to be filled with a pre-determined quantity of fluid is defined by a preferably cylindrical circular cup-shaped body 11 to which this end of the said tube-shaped element is arranged in such a way that the open end is situated at the bottom of the cup-shaped body so that the fluid present in the cup can be inhaled through the tube-shaped element 4 ' .
The present invention is not limited to the embodiments shown and described here, as other embodiments are naturally possible within the scope of the idea of the invention stated in the following claims.

Claims

Claims
1. Method for administering a quantity of fluid to the nose, characterised by the use of a tube-shaped element that has a holder at one end that can be filled with a pre-determined quantity of fluid by being immersed in the said fluid, whereby the fluid can then be administered to a nostril via the other end of the tube-shaped element.
2. Method according to claim 1 characterised in that the tube-shaped element is essentially U-shaped with a shorter and a longer shank (3, 4) and that the U-shaped section is filled with fluid by immersing this and the short shank (3) in the fluid and that the quantity of fluid is then administered to a nostril through the longer shank (4).
3. Method according to claim 2 characterised in that the fluid is then administered to a nostril by the longer shank (4) being held tightly to seal against the nostril while the other nostril is sealed-off and the fluid inhaled.
4. Method according to any of the previous claims characterised in mat the fluid comprises a physiological saline solution.
5. Device for administering a quantity of fluid to the nose, characterised in that it includes a tube-shaped element that has a holder at one end that can be filled with a predetermined quantity of fluid by being immersed in the fluid, and that the opening of the tube- shaped element at one end is located adjacent to the bottom of the holder.
6. Device according to claim 5 characterised in that the tube-shaped element is essentially U-shaped with a short shank (3) and a long shank (4) and that the length of the short shank (3) and the tube's (1) dimensions are adapted to the amount of fluid (6) that is to be administered.
7. Device according to claim 6 characterised in that the long shank (4) is designed with a widened section (7) at one end for sealing against a nostril.
8. Device according to claim 6 characterised in that the widened section (7) has an essentially cone-shaped surface (9) on the side that is pointed towards the patient (10) when being used.
9. Device according to any of claims 5 - 8 characterised in that the fluid (6) consists of physiological saline.
PCT/SE1998/001337 1997-08-05 1998-07-07 Method and device for administering a quantity of fluid to the nose WO1999007427A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU83655/98A AU8365598A (en) 1997-08-05 1998-07-07 Method and device for administering a quantity of fluid to the nose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702861-7 1997-08-05
SE9702861A SE509708C2 (en) 1997-08-05 1997-08-05 Method and apparatus for self-administration of a liquid amount to the nose

Publications (1)

Publication Number Publication Date
WO1999007427A1 true WO1999007427A1 (en) 1999-02-18

Family

ID=20407875

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1998/001337 WO1999007427A1 (en) 1997-08-05 1998-07-07 Method and device for administering a quantity of fluid to the nose

Country Status (3)

Country Link
AU (1) AU8365598A (en)
SE (1) SE509708C2 (en)
WO (1) WO1999007427A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1544164A (en) * 1924-02-18 1925-06-30 Frederick A Marsh Insufflator
US3847145A (en) * 1973-04-13 1974-11-12 M Grossan Nasal irrigation system
SE430756B (en) * 1980-05-16 1983-12-12 Gerhard Hansen DEVICE FOR SELF-ADMINISTRATED INHIBITION OF A POWDER-SHEET OR LIQUID SUBSTANCE IN A BODY ASSEMBLY, IN PARTICULAR NESAN
US5417652A (en) * 1993-12-15 1995-05-23 Scott, Sr.; Jack J. Device and method for administering fluid to the nose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1544164A (en) * 1924-02-18 1925-06-30 Frederick A Marsh Insufflator
US3847145A (en) * 1973-04-13 1974-11-12 M Grossan Nasal irrigation system
SE430756B (en) * 1980-05-16 1983-12-12 Gerhard Hansen DEVICE FOR SELF-ADMINISTRATED INHIBITION OF A POWDER-SHEET OR LIQUID SUBSTANCE IN A BODY ASSEMBLY, IN PARTICULAR NESAN
US5417652A (en) * 1993-12-15 1995-05-23 Scott, Sr.; Jack J. Device and method for administering fluid to the nose

Also Published As

Publication number Publication date
SE9702861L (en) 1999-02-06
AU8365598A (en) 1999-03-01
SE9702861D0 (en) 1997-08-05
SE509708C2 (en) 1999-03-01

Similar Documents

Publication Publication Date Title
US5116311A (en) Method for drug administration
US4886493A (en) Medical applicator process
US5797390A (en) Nasal inhaler having a directed spray pattern
ES2829915T3 (en) Nasal administration
US20050228337A1 (en) Transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
WO2000053252A1 (en) Device and method for delivering a material into the paranasal sinus cavities
US9370632B2 (en) Nasal treatment delivery device for mixed carbon dioxide and saline
US10052464B2 (en) Low flow rate nasal treatment delivery device for mixed carbon dioxide and saline
JPH02168964A (en) Aerosol device
US5024600A (en) Periodontal scaler-like medicinal fluid applicator
JP5241236B2 (en) Apparatus and method for facilitating direct delivery of vapor particles directly into the nasal cavity
US20200188623A1 (en) Clip-on nasal air humidifying and epistaxis-prevention device and methods for use with supplemental oxygen
NO20021681L (en) Device for delivery of drug, with moisture-resistant coating
US9861578B1 (en) Sublingual dosimetric drip caged ball valve device
WO1999007427A1 (en) Method and device for administering a quantity of fluid to the nose
CN201085740Y (en) Rhinobyon type medical stick floss for nasal cavity
JP2016528958A (en) Oral drug delivery device and method of using the oral drug delivery device
US4216768A (en) Device for inhaling powdered substance
AU2013400183B2 (en) Carbon dioxide and saline nasal delivery methods and delivery devices
JPH02500718A (en) injection device
US20170224936A1 (en) Nasal treatment delivery device with carbon dioxide and saline, and methods
GB2479586A (en) Nasal inhaler with medicament cartridge
CA3167084A1 (en) Method, apparatus and kit for treating chronic and long-term nasal congestion
CA3013821C (en) Nasal treatment delivery device with carbon dioxide and saline, and methods, including low flow rates
JPH0529703Y2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09485196

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA